Scatterplot of observed barrier scores against knowledge scores (top) and confidence scores (bottom) with linear line of best fit. by Lisa Thiele (6468056)

Subjects:

Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16]. by Lisa Thiele (6468056)

Subjects:

Respondent characteristics. by Lisa Thiele (6468056)

Subjects:

Predicted confidence scores and 95% confidence intervals for the range of observed knowledge scores for barrier scores of 12, 23 and 36. by Lisa Thiele (6468056)

Subjects:

Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Association between Sociodemographic and level of knowledge, perception, and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Association between sociodemographic and level of knowledge, perception and acceptance of the respondents. by Adaobi Uchenna Mosanya (20384248)

Subjects:

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

Subjects:

Disruption of the <i>pcnB</i> gene encoding poly(A) polymerase PAP I decreases pYV PCN as well as T3SS expression and activity. by Katherine Schubert (5452712)

Political events and impacts in different periods. by Jie Li (15030)

Subjects:

Effects of finerenone on the urinary β2-MG levels in all patients. by Jia Song (495396)

Subjects:

The images of malignant tumors before contrast agent injection, the highest contrast and the contract decreases. by Liang Zhao (94728)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Subjects:

Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

Tumor volume measurements. by Hedieh Zargaran (21410233)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

“…The red line represents the significance threshold (<i>P < </i>5 × 10⁻⁸). …”